SIBN News and Press, SI-BONE Inc. From 06/02/22

Aurora Spine has three products, DEXA, SILO, and ZIP that have been met with early strong market interest evidenced by sequential quarterly revenue growth exceeding 20% over the last year. DEXA is the first commercially available technology that provides customized devices matching an...

SI-BONE (NASDAQ:SIBN) said its received the U.S. Food and Drug Administration's (FDA) 510(k) premarket clearance for its iFuse Bedrock Granite Implant System for use in pelvic fixation. The company said the Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundati...

SANTA CLARA, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announces FDA 510(k) premarket clearance of the iFuse Bedrock Granite Implant Sy...

SI-BONE, Inc. (SIBN) Q1 2022 Earnings Conference Call May 09, 2022, 04:30 PM ET Company Participants Matt Basco - IR, Gilmartin Group Laura Francis - Chief Executive Officer Anshul Maheshwari - Chief Financial Officer Conference Call Participants Craig Bijou - Bank of America Drew Ranieri - M...

The following slide deck was published by SI-BONE, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: SI-BONE, Inc. 2022 Q1 - Results - Earnings Call Presentation

SI-BONE press release (NASDAQ:SIBN): Q1 GAAP EPS of -$0.52 misses by $0.10. Revenue of $22.44M (+9.8% Y/Y) beats by $0.57M. For further details see: SI-BONE GAAP EPS of -$0.52 misses by $0.10, revenue of $22.44M beats by $0.57M

SANTA CLARA, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2022. Recent Highlights Wor...

SANTA CLARA, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the Centers for Medicare and Medicaid Services (CMS) has propos...

SANTA CLARA, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2022 Bank of America Healthcare Co...

SANTA CLARA, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2022 after market close on Mond...